CryoPort, Inc. is a leading transportation company based in the United States, specializing in integrated temperature-controlled supply chain solutions for the life sciences industry. With a risk rating score of 24.9, the company is classified as having a medium risk assessment. CryoPort serves the biopharma/pharma, animal health, and reproductive medicine markets globally, with a focus on ESG practices. Operating in the Americas, Europe, Middle East, Africa, and Asia Pacific regions, CryoPort generates a majority of its revenue from the Americas.